Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Nitric oxide synthase, inducible | 0.0052 | 0.1972 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.2755 | 0.2755 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0059 | 0.2806 | 0.5 |
Trypanosoma cruzi | ion transport protein, putative | 0.0098 | 0.7769 | 1 |
Brugia malayi | flavodoxin family protein | 0.0059 | 0.2806 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0059 | 0.2806 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0059 | 0.2806 | 0.1438 |
Chlamydia trachomatis | sulfite reductase | 0.0036 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.2806 | 0.2806 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0059 | 0.2806 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0059 | 0.2806 | 0.2806 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0059 | 0.2806 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0059 | 0.2806 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0052 | 0.1972 | 0.5 |
Echinococcus multilocularis | small conductance calcium activated potassium | 0.0116 | 1 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0059 | 0.2806 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0059 | 0.2806 | 0.2806 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0059 | 0.2806 | 0.2806 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0059 | 0.2806 | 0.2806 |
Trypanosoma cruzi | ion transport protein, putative | 0.0098 | 0.7769 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0059 | 0.2806 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0059 | 0.2806 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 1 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.011 | 0.9292 | 0.9292 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0059 | 0.2806 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0116 | 1 | 1 |
Leishmania major | ion transport protein-like protein | 0.0098 | 0.7769 | 1 |
Leishmania major | p450 reductase, putative | 0.0059 | 0.2806 | 0.1438 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0059 | 0.2806 | 0.2806 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0059 | 0.2806 | 0.2806 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.2008 | 0.2008 |
Schistosoma mansoni | hypothetical protein | 0.0116 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 5 ug/ml | DNDI: Inhibition of Human African Trypanosomiasis, SBRI 427, in vitro | ChEMBL. | No reference |
IC50 | > 10 ug/ml | DNDI: Cytotoxicity against L929 mouse fibroblasts, 72 hour. | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Trypanosoma brucei | ChEMBL23 | ||
Mus musculus | ChEMBL23 | ||
Trypanosoma brucei gambiense |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.